Last 47 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
LivaNova PLC's quarterly P/E stands at 39.7x. EV/EBITDA has expanded 145.8% YoY to 20.2x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -15.94 | 39.73 | 26.99 | 26.72 | 22.51 | — | 11.35 | 21.89 | 45.68 | — | 43.12 | — | 642.88 |
| — | — | +137.8% | +22.1% | -50.7% | — | -73.7% | — | -92.9% | — | -90.3% | — | +1134.9% | |
| P/S Ratio | 2.79 | 2.45 | 2.32 | 2.02 | 1.75 | 1.69 | 1.97 | 2.25 | 2.35 | 2.56 | 2.26 | 2.50 | 2.36 |
| — | +45.4% | +18.1% | -10.4% | -25.6% | -34.1% | -13.1% | -9.7% | -0.6% | +14.9% | -16.7% | -7.2% | -28.9% | |
| P/B Ratio | 3.22 | 2.93 | 2.79 | 2.50 | 2.19 | 2.07 | 1.92 | 2.19 | 2.41 | 2.47 | 2.20 | 2.33 | 2.24 |
| — | +41.9% | +45.6% | +14.1% | -8.9% | -16.4% | -12.7% | -6.1% | +7.6% | +29.2% | -11.1% | -1.7% | -15.1% | |
| P/FCF | 22.40 | 986.95 | 16.70 | 11.63 | 12.89 | 40.56 | 9.27 | 21.83 | 23.98 | 210.77 | 17.11 | 75.80 | — |
| — | +2333.3% | +80.1% | -46.7% | -46.3% | -80.8% | -45.8% | -71.2% | — | +369.2% | -78.1% | +230.2% | — | |
| EV / EBITDA | 15.40 | 20.17 | 18.70 | 10.31 | 8.49 | 8.20 | 14.02 | 16.42 | 15.92 | 28.83 | — | 41.48 | 22.18 |
| — | +145.8% | +33.4% | -37.2% | -46.6% | -71.5% | — | -60.4% | -28.2% | -39.6% | — | — | +17.1% | |
| EV / EBIT | 18.64 | — | 16.82 | 15.26 | 12.90 | — | 9.62 | 13.27 | 22.50 | — | — | 62.32 | 35.68 |
| — | — | +74.7% | +15.0% | -42.7% | — | — | -78.7% | -36.9% | — | — | — | +36.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
LivaNova PLC's operating margin was 11.5% in Q1 2026, down 0.4 pp QoQ and down 3.9 pp YoY. This marks the 4th consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 13.4% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 3.5% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.7% | 67.3% | 66.4% | 68.4% | 67.8% | 69.7% | 68.2% | 70.8% | 67.4% | 70.3% | 61.3% | 70.5% | 69.8% |
| — | -3.5% | -2.5% | -3.3% | +0.5% | -0.9% | +11.2% | +0.4% | -3.4% | +6.4% | -8.2% | +4.2% | -3.7% | |
| Operating Margin | 14.4% | 11.5% | 11.8% | 15.1% | 15.4% | 15.3% | 11.5% | 11.2% | 12.6% | 5.5% | -28.4% | 1.6% | 5.9% |
| — | -25.3% | +2.7% | +34.8% | +21.9% | +178.5% | +140.5% | +618.6% | +113.2% | +719.6% | -658.6% | +103.0% | -52.7% | |
| Net Margin | -17.5% | 6.2% | 8.6% | 7.5% | 7.7% | -103.3% | 17.4% | 10.4% | 5.1% | -14.2% | 5.3% | -2.6% | 0.4% |
| — | +106.0% | -50.7% | -27.7% | +50.3% | -626.4% | +229.6% | +505.0% | +1204.6% | -608.3% | +771.8% | +94.0% | -93.9% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -19.2% | 1.8% | 2.6% | 2.4% | 2.5% | -27.8% | 4.2% | 2.6% | 1.3% | -3.4% | 1.3% | -0.6% | 0.1% |
| — | +106.7% | -38.4% | -9.0% | +90.0% | -728.3% | +225.5% | +535.0% | +1316.3% | -654.5% | +825.2% | +93.3% | -92.7% | |
| ROA | -9.5% | 0.9% | 1.2% | 1.1% | 1.1% | -12.9% | 2.2% | 1.3% | 0.7% | -1.7% | 0.7% | -0.3% | 0.0% |
| — | +106.7% | -46.2% | -20.1% | +61.3% | -653.3% | +223.7% | +522.8% | +1235.1% | -634.2% | +831.8% | +93.4% | -92.8% | |
| ROIC | 11.5% | 3.0% | 3.1% | 4.0% | 4.1% | 2.9% | 1.7% | 1.7% | 1.9% | 0.8% | -4.0% | 0.2% | 1.0% |
| — | +6.2% | +81.6% | +144.0% | +116.0% | +281.5% | +142.8% | +627.1% | +90.2% | +711.9% | -639.2% | +103.0% | -42.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
LivaNova PLC's Debt/EBITDA ratio is 8.1x, down from 11.1x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 15.8% YoY to 1.33x, tightening the short-term liquidity position. Debt/Equity has declined for 5 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.39 | 0.28 | 0.39 | 0.42 | 0.43 | 0.66 | 0.51 | 0.52 | 0.55 | 0.55 | 0.50 | 0.51 | 0.50 |
| — | -57.9% | -23.1% | -19.0% | -21.1% | +18.3% | +2.3% | +2.4% | +8.4% | +17.0% | +4.3% | +0.6% | +26.9% | |
| Debt / EBITDA | 1.96 | 8.06 | 11.10 | 7.34 | 6.97 | 10.71 | 13.64 | 13.95 | 12.92 | 23.03 | — | 31.77 | 19.31 |
| — | -24.7% | -18.7% | -47.3% | -46.0% | -53.5% | — | -56.1% | -33.1% | -50.0% | — | — | +74.7% | |
| Current Ratio | 1.36 | 1.33 | 1.36 | 1.33 | 1.29 | 1.58 | 2.87 | 3.37 | 3.45 | 3.17 | 2.95 | 3.23 | 3.27 |
| — | -15.8% | -52.6% | -60.7% | -62.7% | -50.2% | -2.6% | +4.4% | +5.7% | +11.1% | -1.0% | +9.3% | +11.7% | |
| Quick Ratio | 1.16 | 1.11 | 1.16 | 1.12 | 1.09 | 1.37 | 2.50 | 2.87 | 2.94 | 2.71 | 2.51 | 2.68 | 2.73 |
| — | -18.8% | -53.6% | -60.9% | -63.0% | -49.3% | -0.4% | +7.0% | +8.0% | +12.5% | -1.4% | +5.9% | +10.2% | |
| Interest Coverage | -3.48 | 5.00 | 2.40 | 4.12 | 3.71 | -19.65 | 4.58 | 3.80 | 2.39 | -1.15 | -5.04 | 0.87 | 1.36 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying LIVN stock.
LivaNova PLC's current P/E is -15.9x. The average P/E over the last 4 quarters is 29.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
LivaNova PLC's current operating margin is 14.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking LivaNova PLC's business trajectory between earnings reports.